A lack of dopamine leads to a decline in motor skills, resulting in difficulty walking and involuntary trembling. As the disease progresses it can lead to dementia. The trial strategy is to derive dopaminergic progenitors from iPS cells and inject them into the putamen, a round structure located at the base of the forebrain. Studies in animals have shown that the progenitors differentiate into dopaminergic neurons inside the body and engraft into the brain. Rather than make patient-specific iPS cells, CiRA has adopted the strategy of deriving stocks of iPS cells from healthy donors with specific cell types that are less likely to cause immune rejection.
More from News
The NIH warn that the prevalence of this neurodegenerative condition is only going to increase unless researchers come up with new and better treatments. Currently, the most common therapy uses the drug levodopa to stimulate dopamine production in certain neurons associated with motor skills. These dopaminergic neurons are situated in the nigrostriatal pathway , which is a brain circuit that connects neurons in the substantia nigra pars compacta with the dorsal striatum. However, levodopa has a wide array of side effects , from physiological to psychological ones. Also, in the long-term, the benefits of such dopamine-regulating drugs are limited. There is still no cure, and medications only go part way to fully treat[ing] incoordination and movement problems. In their review, Dr. Henchcliffe and Prof.
Treatment of Parkinson’s disease using human stem cells
This is a guest post from The Michael J. Stem cells are valuable tools in that work, helping develop new therapies and learn more about the disease. Find out more about the work they do at www. Parkinson's disease is a neurological disorder that affects one in people over age The disease causes a variety of symptoms including motor problems such as tremors, muscle rigidity and slowed movement, and non-motor symptoms of cognitive impairment, mood disorders, and autonomic dysfunction. Current treatments can ease some symptoms, but no available therapies stop or slow the progression of the disease.
View research View latest news Sign up for updates. Metrics details. Stem cells hold tremendous promise for regenerative medicine because they can be expanded infinitely, giving rise to large numbers of differentiated cells required for transplantation. Stem cells can be derived from fetal sources, embryonic origins embryonic stem cells or ESCs or reprogrammed from adult cell types induced pluripotent stem cells or iPSCs. One unique property of stem cells is their ability to be directed towards specific cell types of clinical interest, and can mature into functional cell types in vivo. However, even with these benefits, cell therapy comes with significant hurdles that researchers are starting to overcome. Early trials using fetal midbrain material in the late s have resulted in long term benefit for some patients, but there were multiple shortcomings including the non-standardization and quality control of the transplanted fetal material, and graft-induced dyskinesia that some patients experience as a result.